Početna stranicaMANKIND • NSE
add
Mankind Pharma Ltd
Preth. zaklj. cijena
2.647,20 ₹
Dnevni raspon
2.626,00 ₹ - 2.685,15 ₹
Godišnji raspon
1.683,05 ₹ - 2.835,00 ₹
Tržišna kapitalizacija
1,07 bil. INR
Prosječna količina
478,22 tis.
P/E omjer
54,49
Prinos dividende
-
Glavno tržište vrijednosnica
NSE
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (INR) | lip 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 28,93 mlr. | 12,21 % |
Operativni troškovi | 15,07 mlr. | 26,50 % |
Neto dohodak | 5,36 mlr. | 10,19 % |
Neto profitabilnost | 18,54 | −1,80 % |
Zarada po dionici | 13,37 | 10,13 % |
EBITDA | 6,70 mlr. | 3,28 % |
Efektivna porezna stopa | 18,66 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (INR) | lip 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 33,86 mlr. | 121,53 % |
Ukupna imovina | — | — |
Ukupne obveze | — | — |
Ukupni kapital | 95,76 mlr. | — |
Dionice u optjecaju | 400,64 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 11,33 | — |
Povrat imovine | — | — |
Povrat kapitala | 14,67 % | — |
Tok novca
Neto promjena novca
| (INR) | lip 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 5,36 mlr. | 10,19 % |
Gotovina od poslovanja | — | — |
Gotovina iz ulaganja | — | — |
Gotovina iz financiranja | — | — |
Neto promjena novca | — | — |
Slobodan tok novca | — | — |
Više
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Glavni izvršni direktor
Osnovano
1991
Web-lokacija
Zaposlenici
19.540
